Hawthorn Red Combined Refractory Cancer Pain
1 clinical trials · Condition
◉ Watch Hawthorn Red Combined Refractory Cancer Pain
| Record | Firm | Date |
|---|---|---|
| Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain (NCT05561023) | Fujian Cancer Hospital | 2022-10-01 |
Track Hawthorn Red Combined Refractory Cancer Pain automatically
Every clearance here is in the API, with alerts when new ones post.